Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by BeenHereBeforeon Sep 26, 2015 2:17am

170 Views

Post# 24137764

RE:RE:RE:RE:RE:RE:New interview with TLT Investor Relations - Michael Borovec

Your argument is logically unsound.

Having human trials approved does not in any way mean the SP will jump 10X in 12 months.

The trials, IF they even start on time, won't be completed until probably 2017 and I firmly believe that ONLY on news of positive results will this stock pop like all of you pumptards constantly drone on about... and that just ain't happening in 12 months.

bencro wrote: BeenHereBefore ... So 3$ in 12 months is not possible, right?

You should wonder why HC has allowed this to be included in Phase 1B:

... with an exploratory objective of efficacy

The reason is simple. HC recognizes very easily, that contrary to any other drug, PDT can deliver instant results (within 30 minutes) when PDC is light activated. All this is clearly documented.

And because TLT has demonstrated that its PDC fluoresces, then HC knows that data can be collected before and after the light activation. So this authorization to allow for this exploratory objective of efficacy ...

Name us an oncology drug that has instant results within 30 minutes.

So if this exploratory objective of efficacy for a solid tumor is positive, only you can think that the stock price will sit under 3$ after that.

And you're invested in TLT with such a poor understand of what's at stake in terms of valuation and tipping point??? No kidding!